BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiota S, Murakawi K, Suzuki R, Fujioka T, Yamaoka Y. Helicobacter pylori infection in Japan. Expert Rev Gastroenterol Hepatol. 2013;7:35-40. [PMID: 23265147 DOI: 10.1586/egh.12.67] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Dhungel B, Murakami T, Gilmour S, Ikeda S, Wada K. Occupation- and industry-specific cancer mortality among Japanese women from 1980 to 2015. BMC Public Health 2022;22:2003. [PMID: 36320013 DOI: 10.1186/s12889-022-14304-4] [Reference Citation Analysis]
2 Karbalaei M, Keikha M, Talebi Bezmin Abadi A. Prevalence of Primary Multidrug-resistant Helicobacter pylori in Children: A Systematic Review and Meta-analysis. Arch Med Res 2022:S0188-4409(22)00101-1. [PMID: 36089418 DOI: 10.1016/j.arcmed.2022.08.010] [Reference Citation Analysis]
3 Chattopadhyay I, Gundamaraju R, Jha NK, Gupta PK, Dey A, Mandal CC, Ford BM, Nicolazzo C. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer? Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/2941248] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Takahashi Y, Yamamichi N, Kubota D, Shimamoto T, Nagao S, Sakuma N, Sakaguchi Y, Yakabi S, Tsuji Y, Wada R, Mitsushima T, Ichinose M, Fujishiro M. Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study. Gastric Cancer. [DOI: 10.1007/s10120-021-01273-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yamamoto R, Honda M, Kawamura H, Kobayashi H, Takiguchi K, Muto A, Yamazaki S, Teranishi Y, Shiraso S, Kono K, Hori S, Kamiga T, Iwao T, Yamashita N. Clinical Features and Survival of Young Adults with Stage IV Gastric Cancer: a Japanese Population-Based Study. J Gastrointest Cancer 2022. [PMID: 34994916 DOI: 10.1007/s12029-021-00797-6] [Reference Citation Analysis]
6 Vaiphei K. Helicobacter pylori Negative Gastric Cancer. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_16] [Reference Citation Analysis]
7 Loor A, Dumitrascu DL, Surdea-Blaga T, Leucuta DC, David L. Helicobacter pylori infection and positive Rome IV criteria for functional dyspepsia in Romanian medical students. J Med Life 2021;14:492-7. [PMID: 34621372 DOI: 10.25122/jml-2021-0163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hussain Shah SR, Almugadam BS, Hussain A, Ahmad T, Ahmed S, Sadiqui S. Epidemiology and risk factors of Helicobacter pylori infection in Timergara city of Pakistan: A cross-sectional study. Clinical Epidemiology and Global Health 2021;12:100909. [DOI: 10.1016/j.cegh.2021.100909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Miftahussurur M, Waskito LA, Fauzia KA, Mahmudah I, Doohan D, Adnyana IK, Khomsan A, Ratnasari N, Rezkitha YAA. Overview of Helicobacter pylori Infection in Indonesia: What Distinguishes It from Countries with High Gastric Cancer Incidence? Gut Liver 2021;15:653-65. [PMID: 32616679 DOI: 10.5009/gnl20019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Karbalaei M, Hussein NR, Keikha M. Predicting the role of dupA-positive Helicobacter pylori strains in severe gastrointestinal disorders: An updated meta-analysis. Gene Reports 2021;24:101263. [DOI: 10.1016/j.genrep.2021.101263] [Reference Citation Analysis]
11 Abengozar R, Sharma A, Sharma R. Gastric cancer: lessons learned from high-incidence geographic regions. J Gastrointest Oncol 2021;12:S350-60. [PMID: 34422399 DOI: 10.21037/jgo-2019-gi-05] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Takita M, Ohata K, Inamoto R, Kurebayashi M, Takayanagi S, Kimoto Y, Suzuki Y, Ishii R, Ono K, Negishi R, Minato Y, Sakai E, Muramoto T, Matsuhashi N, Ichihara S. Endoscopic and histological features of Helicobacter pylori-negative differentiated gastric adenocarcinoma arising in the antrum. JGH Open 2021;5:470-7. [PMID: 33860098 DOI: 10.1002/jgh3.12518] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Horiuchi S, Nakano R, Nakano A, Hishiya N, Uno K, Suzuki Y, Kakuta N, Kakuta R, Tsubaki K, Jojima N, Yano H. Prevalence of Helicobacter pylori among residents and their environments in the Nara prefecture, Japan. J Infect Public Health 2021;14:271-5. [PMID: 33508684 DOI: 10.1016/j.jiph.2020.11.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kato M, Uedo N, Toth E, Shichijo S, Maekawa A, Kanesaka T, Takeuchi Y, Yamamoto S, Higashino K, Ishihara R, Nemeth A, Thorlacius H, Tomita Y, Wurm Johansson G. Differences in image-enhanced endoscopic findings between Helicobacter pylori -associated and autoimmune gastritis. Endosc Int Open 2021;9:E22-30. [PMID: 33403232 DOI: 10.1055/a-1287-9767] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Yoshinaga Y, Tanaka H, Wada K, Ikeda S. Gastric cancer mortality rates by occupation and industry among male and female workers aged 25-64 years in Japan. Ind Health 2020;58:554-64. [PMID: 32981909 DOI: 10.2486/indhealth.2020-0136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Karbalaei M, Keikha M. Potential association between the hopQ alleles of Helicobacter pylori and gastrointestinal diseases: A systematic review and meta-analysis. Meta Gene 2020;26:100816. [DOI: 10.1016/j.mgene.2020.100816] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
17 Gennari L, Merlotti D, Figura N, Mingiano C, Franci MB, Lucani B, Picchioni T, Alessandri M, Campagna MS, Gonnelli S, Bianciardi S, Materozzi M, Caffarelli C, Gonnelli S, Nuti R. Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study. J Bone Miner Res 2021;36:80-9. [PMID: 32790186 DOI: 10.1002/jbmr.4162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Keikha M. Is there a relationship between Helicobacter pylori vacA i1 or i2 alleles and development into peptic ulcer and gastric cancer? A meta-analysis study on an Iranian population. New Microbes New Infect 2020;36:100726. [PMID: 32714559 DOI: 10.1016/j.nmni.2020.100726] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
19 Pham T, Quy PN, Horimatsu T, Muto M, Shack L, Cheung WY, Kubo T, Fujino Y, Matsuda S. Premature mortality due to stomach cancer in Japan: a nationwide analysis from 1980 to 2015. Annals of Epidemiology 2020;47:19-24. [DOI: 10.1016/j.annepidem.2020.05.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
20 Imai Y, Chiba T, Kondo T, Kanzaki H, Kanayama K, Ao J, Kojima R, Kusakabe Y, Nakamura M, Saito T, Nakagawa R, Suzuki E, Nakamoto S, Muroyama R, Tawada A, Matsumura T, Nakagawa T, Kato J, Kotani A, Matsubara H, Kato N. Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer. Oncol Lett 2020;20:2161-8. [PMID: 32782533 DOI: 10.3892/ol.2020.11757] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
21 Ofori EG, Adinortey CA, Bockarie AS, Kyei F, Tagoe EA, Adinortey MB. Helicobacter pylori Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation. Biomed Res Int 2019;2019:7312908. [PMID: 31886245 DOI: 10.1155/2019/7312908] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
22 Nolen LD, Vindigni SM, Parsonnet J; Symposium leaders. Combating Gastric Cancer in Alaska Native People: An Expert and Community Symposium.Gastroenterology. 2020;158:1197-1201. [PMID: 31836529 DOI: 10.1053/j.gastro.2019.11.299] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
23 Kubosawa Y, Mori H, Kinoshita S, Nakazato Y, Fujimoto A, Kikuchi M, Nishizawa T, Suzuki M, Suzuki H. Changes of gastric ulcer bleeding in the metropolitan area of Japan. World J Gastroenterol 2019; 25(42): 6342-6353 [PMID: 31754294 DOI: 10.3748/wjg.v25.i42.6342] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
24 Hoshino I, Gunji H, Ishige F, Iwatate Y, Takiguchi N, Ikeda A, Soda H, Tonooka T, Sato N, Kawahara K, Nabeya Y. Surgical treatment strategy for esophagogastric junction cancers based on the tumor diameter. BMC Surg 2019;19:152. [PMID: 31651313 DOI: 10.1186/s12893-019-0614-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
25 Funaki Y, Ogasawara N, Kawamura Y, Yoshimine T, Tamura Y, Izawa S, Ebi M, Sasaki M, Kasugai K. Effects of acotiamide on functional dyspepsia patients with heartburn who failed proton pump inhibitor treatment in Japanese patients: A randomized, double-blind, placebo-controlled crossover study. Neurogastroenterol Motil 2020;32:e13749. [PMID: 31612597 DOI: 10.1111/nmo.13749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Doohan D, Miftahussurur M, Matsuo Y, Kido Y, Akada J, Matsuhisa T, Yee TT, Htet K, Aftab H, Vilaichone RK, Mahachai V, Ratanachu-Ek T, Tshering L, Waskito LA, Fauzia KA, Uchida T, Syam AF, Rezkitha YAA, Yamaoka Y. Characterization of a novel Helicobacter pylori East Asian-type CagA ELISA for detecting patients infected with various cagA genotypes. Med Microbiol Immunol 2020;209:29-40. [PMID: 31549252 DOI: 10.1007/s00430-019-00634-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
27 Mori H, Suzuki H, Omata F, Masaoka T, Asaoka D, Kawakami K, Mizuno S, Kurihara N, Nagahara A, Sakaki N, Ito M, Kawamura Y, Suzuki M, Shimada Y, Sasaki H, Matsuhisa T, Torii A, Nishizawa T, Mine T, Ohkusa T, Kawai T, Tokunaga K, Takahashi S. Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients. Therap Adv Gastroenterol. 2019;12:1756284819858511. [PMID: 31320930 DOI: 10.1177/1756284819858511] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
28 Mladenova I, Grekova O, Kirova D, Petrov D, Patel A. Investigations of families of patients diagnosed with gastric carcinoma in Bulgaria. Clinical Epidemiology and Global Health 2019;7:211-213. [DOI: 10.1016/j.cegh.2018.06.002] [Reference Citation Analysis]
29 Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Sci Rep. 2019;9:6099. [PMID: 30988344 DOI: 10.1038/s41598-019-42365-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
30 Bhide A, Datar S, Stebbins K. Case Histories of Significant Medical Advances: Eradicating Helicobacter Pylori Infections to Treat Ulcers. SSRN Journal. [DOI: 10.2139/ssrn.3429959] [Reference Citation Analysis]
31 Honma H, Nakayama Y, Kato S, Hidaka N, Kusakari M, Sado T, Suda A, Lin Y. Clinical features of Helicobacter pylori antibody-positive junior high school students in Nagano Prefecture, Japan. Helicobacter 2019;24:e12559. [PMID: 30515905 DOI: 10.1111/hel.12559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
32 Kono Y, Kanzaki H, Tsuzuki T, Takatani M, Nasu J, Kawai D, Takenaka R, Tanaka T, Iwamuro M, Kawano S, Kawahara Y, Fujiwara T, Okada H. A multicenter observational study on the clinicopathological features of gastric cancer in young patients. J Gastroenterol 2019;54:419-26. [DOI: 10.1007/s00535-018-1525-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Isono Y, Baba Y, Mukai K, Asakawa H, Nose K, Tsuruga S, Tochio T, Kumazawa H, Tanaka H, Matsusaki S, Sase T, Saito T, Okano H, Toyoda H. Gastric adenocarcinoma coexisting with a reddish semipedunculated polyp arising from Helicobacter pylori-negative normal gastric mucosa: a report of two cases. Clin J Gastroenterol 2018;11:481-6. [PMID: 30022297 DOI: 10.1007/s12328-018-0887-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
34 Tsuruoka N, Iwakiri R, Sakata Y, Fujimoto K, Kamiya T, Joh T, Tokunaga K, Takahashi S, Kinoshita Y, Uchiyama K, Naito Y, Nagahara A, Watanabe T, Chan FKL, Hahm KB, Kachintorn U, Fock KM, Syam AF, Rani AA, Sollano JD, Zhu Q. Questionnaire-Based Survey on Gastrointestinal Bleeding and Management of Antithrombotic Agents during Endoscopy Among Asian Countries. Digestion 2018;97:97-106. [PMID: 29402809 DOI: 10.1159/000484228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
35 Ruiz-narváez CE, Martínez-rodríguez JE, Cedeño-burbano AA, Erazo-tapia JM, Pabón-fernández CD, Unigarro-benavides LV, Buitrón-zúñiga EL, Burbano-imbachí A. Helicobacter pylori, úlcera péptica y cáncer gástrico. Rev Fac Med 2018;66:103-106. [DOI: 10.15446/revfacmed.v66n1.58953] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Espinoza JL, Matsumoto A, Tanaka H, Matsumura I. Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies. Cancer Lett. 2018;414:147-152. [PMID: 29138097 DOI: 10.1016/j.canlet.2017.11.009] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
37 Alkebsi L, Ideno Y, Lee JS, Suzuki S, Nakajima-Shimada J, Ohnishi H, Sato Y, Hayashi K. Gastroduodenal Ulcers and ABO Blood Group: the Japan Nurses' Health Study (JNHS). J Epidemiol 2018;28:34-40. [PMID: 29093357 DOI: 10.2188/jea.JE20160204] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
38 Hiroi S, Sugano K, Tanaka S, Kawakami K. Impact of health insurance coverage for Helicobacter pylori gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data. BMJ Open 2017;7:e015855. [PMID: 28760790 DOI: 10.1136/bmjopen-2017-015855] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
39 Osaki T, Mabe K, Zaman C, Yonezawa H, Okuda M, Amagai K, Fujieda S, Goto M, Shibata W, Kato M, Kamiya S. Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy. Helicobacter. 2017;22 . [PMID: 28544222 DOI: 10.1111/hel.12396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
40 Nakayama Y, Lin Y, Hongo M, Hidaka H, Kikuchi S. Helicobacter pylori infection and its related factors in junior high school students in Nagano Prefecture, Japan. Helicobacter 2017;22:e12363. [DOI: 10.1111/hel.12363] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
41 Nair MR, Chouhan D, Sen Gupta S, Chattopadhyay S. Fermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer? Front Microbiol 2016;7:1148. [PMID: 27504109 DOI: 10.3389/fmicb.2016.01148] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
42 Okimoto E, Ishimura N, Morito Y, Mikami H, Shimura S, Uno G, Tamagawa Y, Aimi M, Oshima N, Kawashima K. Prevalence of gastroesophageal reflux disease in children, adults, and elderly in the same community. J Gastroenterol Hepatol. 2015;30:1140-1146. [PMID: 25611309 DOI: 10.1111/jgh.12899] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
43 Kanno T, Iijima K, Abe Y, Yagi M, Asonuma S, Ohyauchi M, Ito H, Koike T, Shimosegawa T. Helicobacter pylori-negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence: Multicenter follow-up study of peptic ulcers in Japan. Dig Endosc. 2016;28:556-563. [PMID: 26866510 DOI: 10.1111/den.12635] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
44 Kim N. Prevalence and Transmission Routes of H. pylori. Helicobacter pylori 2016. [DOI: 10.1007/978-981-287-706-2_1] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
45 Watanabe M, Ito H, Hosono S, Oze I, Ashida C, Tajima K, Katoh H, Matsuo K, Tanaka H. Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population. Cancer Sci 2015;106:1738-43. [PMID: 26395018 DOI: 10.1111/cas.12821] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
46 Ishimura N, Mori M, Mikami H, Shimura S, Uno G, Aimi M, Oshima N, Ishihara S, Kinoshita Y. Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers. BMC Gastroenterol 2015;15:117. [PMID: 26362795 DOI: 10.1186/s12876-015-0346-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
47 Shiota S, Yamaoka Y. Biomarkers for Helicobacter pylori infection and gastroduodenal diseases. Biomark Med 2014;8:1127-37. [PMID: 25402582 DOI: 10.2217/bmm.14.72] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
48 Iijima K, Shimosegawa T. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury. World J Gastroenterol 2015; 21(25): 7709-7717 [PMID: 26167071 DOI: 10.3748/wjg.v21.i25.7709] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
49 Yamamoto Y, Fujisaki J, Omae M, Hirasawa T, Igarashi M. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27:551-561. [PMID: 25807972 DOI: 10.1111/den.12471] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 10.0] [Reference Citation Analysis]
50 Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter 2015;20:239-51. [PMID: 25728540 DOI: 10.1111/hel.12200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
51 Mizuno S, Matsui D, Watanabe I, Ozaki E, Kuriyama N, Watanabe Y. Serologically Determined Gastric Mucosal Condition Is a Predictive Factor for Osteoporosis in Japanese Men. Dig Dis Sci 2015;60:2063-9. [DOI: 10.1007/s10620-015-3576-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
52 Myint T, Shiota S, Vilaichone RK, Ni N, Aye TT, Matsuda M, Tran TTH, Uchida T, Mahachai V, Yamaoka Y. Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar. World J Gastroenterol 2015; 21(2): 629-636 [PMID: 25605987 DOI: 10.3748/wjg.v21.i2.629] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
53 Osaki T, Konno M, Yonezawa H, Hojo F, Zaman C, Takahashi M, Fujiwara S, Kamiya S. Analysis of intra-familial transmission of Helicobacter pylori in Japanese families. Journal of Medical Microbiology 2015;64:67-73. [DOI: 10.1099/jmm.0.080507-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
54 Iijima K, Koike T, Abe Y, Ohara S, Nakaya N, Shimosegawa T. Time series analysis of gastric acid secretion over a 20-year period in normal Japanese men. J Gastroenterol 2015;50:853-61. [DOI: 10.1007/s00535-014-1031-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
55 Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev. 2014;CD010623. [PMID: 25464111 DOI: 10.1002/14651858.cd010623.pub2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
56 Nagashima H, Iwatani S, Cruz M, Jiménez Abreu JA, Tronilo L, Rodríguez E, Disla M, Terao H, Uchida T, Mahachai V, Vilaichone RK, Tshering L, Mitsui T, Shiota S, Graham DY, Yamaoka Y. Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic. Hum Pathol 2015;46:129-36. [PMID: 25454482 DOI: 10.1016/j.humpath.2014.10.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
57 Lee JY, Kim N. [Future trends of Helicobacter pylori eradication therapy in Korea]. Korean J Gastroenterol. 2014;63:158-170. [PMID: 24651589 DOI: 10.4166/kjg.2014.63.3.158] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
58 Lee SY. Current progress toward eradicating Helicobacter pylori in East Asian countries: Differences in the 2013 revised guidelines between China, Japan, and South Korea. World J Gastroenterol 2014; 20(6): 1493-1502 [PMID: 24587624 DOI: 10.3748/wjg.v20.i6.1493] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
59 Ueda J, Gosho M, Inui Y, Matsuda T, Sakakibara M, Mabe K, Nakajima S, Shimoyama T, Yasuda M, Kawai T, Murakami K, Kamada T, Mizuno M, Kikuchi S, Lin Y, Kato M. Prevalence of Helicobacter pylori infection by birth year and geographic area in Japan. Helicobacter. 2014;19:105-110. [PMID: 24506211 DOI: 10.1111/hel.12110] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 8.4] [Reference Citation Analysis]
60 Song H, Lu D, Zhu J. Long term proton pump inhibitor (PPI) use and incidence of gastric premalignant lesions. Cochrane Database of Systematic Reviews 2013. [DOI: 10.1002/14651858.cd010623] [Reference Citation Analysis]